- Home
- Mutual Funds
- Bajaj Finserv Mutual Fund
- Bajaj Finserv Healthcare Fund Direct-growth
Fund Overview of Bajaj Finserv Healthcare Fund Direct-growth
-
₹332.5 CrAUM
-
₹10.74NAV
-
0.78%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Bajaj Finserv Healthcare Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 14.39% | NA | 6.12% |
| 6 Months | 10.20% | NA | 12.92% |
| 1 Year | 12.12% | 12.12% | 6.04% |
Compare Bajaj Finserv Healthcare Fund Direct-growth with other mutual funds in the same category
Bajaj Finserv Healthcare Fund Direct-growth
SBI Healthcare Opportunities Fund Direct Plan-growth
SBI Healthcare Opportunities Fund Direct Plan-idcw
Asset Allocation
equities
95.80%debt instruments
3.06%other assets or cash equivalents
1.14%Bajaj Finserv Healthcare Fund Direct-growth is one Equity mutual fund offered by Bajaj Finserv Mutual Fund. Launched on 27 Dec 2024, the fund aims Wealth creation over long term. To invest predominantly in equity and equity related instruments of pharma, healthcare and allied companies. It manages assets worth ₹332.5 crore as on Sun May 31, 2026. The expense ratio stands at 0.78%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Bajaj Finserv Healthcare Fund Direct-growth
The portfolio allocation consists of 95.80% in equities, 3.06% in debt instruments, 1.14% in other assets or cash equivalents.Managed by Sorbh Gupta, it has delivered a return of 12.12% in the last year, a total return since inception of 4.99%.
Choosing the right best sip plans has an important role in long-term wealth creation.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
SBI Healthcare Opportunities Fund Direct Plan-growth  |
₹4,566 | 1.67% | 13.30% | 10.49% | 24.74% | 16.80% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,566 | 1.67% | 13.30% | 10.49% | 24.74% | 16.80% |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth  |
₹6,454 | -1.21% | 11.20% | 7.32% | 26.34% | 16.48% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | -1.21% | 11.20% | 7.32% | 26.34% | 16.48% |
| Mirae Asset Healthcare Fund Direct-growth |
₹3,091 | -0.79% | 9.54% | 13.22% | 24.88% | 15.73% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹3,091 | -0.79% | 9.54% | 13.22% | 24.88% | 15.73% |
| DSP Healthcare Fund Direct-growth |
₹3,309 | 3.03% | 14.21% | 8.50% | 22.68% | 15.62% |
| DSP Healthcare Fund Direct-idcw |
₹3,309 | 3.03% | 14.21% | 8.50% | 22.68% | 15.62% |
| SBI Healthcare Opportunities Fund-growth |
₹4,566 | 1.58% | 13.02% | 9.38% | 23.45% | 15.57% |
| SBI Healthcare Opportunities Fund-idcw |
₹4,566 | 1.58% | 13.02% | 9.38% | 23.45% | 15.57% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Bajaj Finserv Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Bajaj Finserv Healthcare Fund Regular-growth
|
₹333 | 0.82% | 13.91% | 9.29% | 10.27% | - |
|
Bajaj Finserv Healthcare Fund Regular-idcw
|
₹333 | 0.82% | 13.91% | 9.29% | 10.27% | - |
|
Bajaj Finserv Healthcare Fund Direct-idcw
|
₹333 | 0.97% | 14.39% | 10.20% | 12.12% | - |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹8,636 | ₹535.25 | 20.43% | 12.64% | 15.21% |
| Nippon India Pharma Fund Direct-growth |
₹8,636 | ₹601.05 | 21.51% | 13.66% | 16.24% |
| Nippon India Pharma Fund-idcw |
₹8,636 | ₹115.58 | 20.43% | 12.64% | 15.21% |
| Nippon India Pharma Fund Direct-idcw |
₹8,636 | ₹164.49 | 21.51% | 13.66% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,454 | ₹41.36 | 25.28% | 15.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,454 | ₹44.89 | 26.34% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,454 | ₹24.13 | 25.28% | 15.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | ₹27.11 | 26.34% | 16.48% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,566 | ₹468.57 | 23.45% | 15.57% | 13.35% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,566 | ₹541.52 | 24.74% | 16.80% | 14.59% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Divi's Laboratories Ltd | Healthcare | 9.07% | ₹30.15 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.73% | ₹22.37 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 6.54% | ₹21.74 Cr |
| Piramal Pharma Ltd | Healthcare | 6.51% | ₹21.64 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.17% | ₹20.51 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 5.26% | ₹17.48 Cr |
| Rubicon Research Ltd. | 4.52% | ₹15.03 Cr | |
| Neuland Laboratories Ltd | Healthcare | 4.39% | ₹14.59 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 4.18% | ₹13.91 Cr |
| Max Healthcare Institute Ltd | Healthcare | 3.68% | ₹12.24 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.36% | ₹11.16 Cr |
| Zydus Wellness Ltd | Consumer Staples | 2.65% | ₹8.80 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 2.43% | ₹8.08 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.31% | ₹7.70 Cr |
| Shaily Engineering Plastics Ltd | Materials | 2.23% | ₹7.42 Cr |
| Navin Fluorine International Ltd | Materials | 2.14% | ₹7.13 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 2.05% | ₹6.83 Cr |
| Laurus Labs Ltd | Healthcare | 2.05% | ₹6.81 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.91% | ₹6.36 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.90% | ₹6.31 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹541.52 | 24.74% | 16.80% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹376.23 | 24.74% | 16.80% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹44.89 | 26.34% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.11 | 26.34% | 16.48% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.24 | 24.88% | 15.73% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.45 | 24.88% | 15.73% | - |
| DSP Healthcare Fund Direct-growth |
₹46.19 | 22.68% | 15.62% | - |
| DSP Healthcare Fund Direct-idcw |
₹26.71 | 22.68% | 15.62% | - |
| SBI Healthcare Opportunities Fund-growth |
₹468.57 | 23.45% | 15.57% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹295.17 | 23.45% | 15.57% | - |
growth is based on 5Y returns of the funds
Frequently Asked Questions
Bajaj Finserv Healthcare Fund Direct-growth
What is the current AUM of Bajaj Finserv Healthcare Fund Direct-growth?
As of Sun May 31, 2026, Bajaj Finserv Healthcare Fund Direct-growth manages assets worth ₹332.5 crore
How has Bajaj Finserv Healthcare Fund Direct-growth performed recently?
- 3 Months: 14.39%
- 6 Months: 10.20%
What is the long-term performance of Bajaj Finserv Healthcare Fund Direct-growth?
- Since Inception: 4.99%
What is the portfolio composition of Bajaj Finserv Healthcare Fund Direct-growth?
Equity: 95.80%, Debt: 3.06%, Others: 1.14%.
Who manages Bajaj Finserv Healthcare Fund Direct-growth?
Bajaj Finserv Healthcare Fund Direct-growth is managed by Sorbh Gupta from Bajaj Finserv Mutual Fund.
What is the market-cap allocation of Bajaj Finserv Healthcare Fund Direct-growth?
Large Cap: 32.65%, Mid Cap: 23.61%, Small Cap: 43.74%.
Which are the top companies Bajaj Finserv Healthcare Fund Direct-growth has invested in?
- Divi's Laboratories Ltd – 9.07% of the fund's portfolio
- Apollo Hospitals Enterprise Ltd – 6.73% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 6.54% of the fund's portfolio
- Piramal Pharma Ltd – 6.51% of the fund's portfolio
- Aurobindo Pharma Ltd – 6.17% of the fund's portfolio
Which are the major sectors Bajaj Finserv Healthcare Fund Direct-growth focuses on?
- Healthcare – 68.54% of the fund's portfolio
- Other – 4.52% of the fund's portfolio
- Materials – 4.37% of the fund's portfolio
- Consumer Staples – 2.65% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
